Common polymorphisms in antioxidant genes are associated with diabetic nephropathy in Type 2 diabetes patients

被引:0
作者
Klen, Jasna [1 ]
Goricar, Katja [2 ]
Janez, Andrej [3 ]
Dolzan, Vita [2 ]
机构
[1] Gen Hosp Trbovlje, Trbovlje 1420, Slovenia
[2] Univ Ljubljana, Fac Med, Inst Biochem, Pharmacogenet Lab, Vrazov Trg 2, Ljubljana 1000, Slovenia
[3] Univ Med Ctr Ljubljana, Dept Endocrinol Diabet & Metab Dis, Ljubljana 1000, Slovenia
关键词
antioxidative enzymes; CAT; genetic polymorphism; GSTP1; oxidative stress; Type; 2; diabetes; MANGANESE SUPEROXIDE-DISMUTASE; INTENSIVE GLUCOSE CONTROL; S-TRANSFERASES GENOTYPES; OXIDATIVE STRESS; MYOCARDIAL-INFARCTION; MOLECULAR-MECHANISMS; KIDNEY-DISEASE; SUBUNIT GENE; VARIANTS; MELLITUS;
D O I
10.2217/PME.14.86
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aim: To investigate if antioxidative genes' polymorphisms influence the risk for Type 2 diabetes (T2D) complications. Materials & Methods: In total, 181 T2D patients were genotyped for SOD2, CAT, GPX1, GSTP1, GSTM1*0, GSTT1*0, GCLC and GCLM. Results: After adjustment for duration of T2D, CAT rs1001179 and GSTP1 rs1138272 showed strongest association with risk for end-stage kidney failure (p = 0.005 and p = 0.049, respectively). In patients without end-stage kidney failure CAT rs1001179 influenced urea levels (p = 0.003), while GSTP1 rs1695 and GSTP1 haplotypes influenced the risk of moderately increased albuminuria (p = 0.024 and p = 0.014, respectively). Conclusion: Common CAT and GSTP1 polymorphisms could be used to identify T2D patients at an increased risk for developing end-stage kidney failure.
引用
收藏
页码:187 / 198
页数:12
相关论文
共 51 条
[1]  
Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI [10.2337/dc11-S062, 10.2337/dc14-S081, 10.2337/dc11-S011, 10.2337/dc13-S067, 10.2337/dc12-s011, 10.2337/dc10-S011, 10.2337/dc10-S062, 10.2337/dc13-S011, 10.2337/dc12-s064]
[2]   Evaluation of glutathione S-transferase P1 genetic variants affecting type-2 diabetes susceptibility and glycemic control [J].
Amer, Mahmoud A. ;
Ghattas, Maivel H. ;
Abo-ElMatty, Dina M. ;
Abou-El-Ela, Soad H. .
ARCHIVES OF MEDICAL SCIENCE, 2012, 8 (04) :631-636
[3]  
[Anonymous], 2006, Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation
[4]  
[Anonymous], HLA 1998
[5]   New Insights Into Molecular Mechanisms of Diabetic Kidney Disease [J].
Badal, Shawn S. ;
Danesh, Farhad R. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2014, 63 (02) :S63-S83
[6]   Dyslipidemia in patients with type 2 diabetes. Relationships between lipids, kidney disease and cardiovascular disease [J].
Battisti, WP ;
Palmisano, J ;
Keane, WF .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2003, 41 (09) :1174-1181
[7]   Biochemistry and molecular cell biology of diabetic complications [J].
Brownlee, M .
NATURE, 2001, 414 (6865) :813-820
[8]   Chronic Hyperglycemia and Glucose Toxicity: Pathology and Clinical Sequelae [J].
Campos, Carlos .
POSTGRADUATE MEDICINE, 2012, 124 (06) :90-97
[9]   Simultaneous characterization of glutathione S-transfersase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks [J].
Chen, CL ;
Liu, Q ;
Relling, MV .
PHARMACOGENETICS, 1996, 6 (02) :187-191
[10]  
Cilensek I, 2012, DIS MARKERS, V32, P93, DOI [10.3233/DMA-2011-0863, 10.1155/2012/675628]